Biocon Competitors and Similar CompaniesClear all

Biocon's competitors and similar companies include EMS Pharma, Cipla, Sun Pharma and Idorsia.
Biocon
Biocon
Biocon is a company that develops and manufactures biopharmaceutical products.
EMS Pharma
EMS Pharma
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
Cipla
Cipla
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Sun Pharma
Sun Pharma
Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
Idorsia
Idorsia
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
Founding Date
Founding Date
1978
Founding Date
1964
Founding Date
1935
Founding Date
1983
Founding Date
2017
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Bengaluru, IN HQ
Bengaluru, IN
Nanakramguda, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
Delémont, CH
see more
Locations
BR HQ
Locations
Mumbai, IN HQ
Melbourne, AU
Antwerpen, BE
São Paulo, BR
São Paulo, BR
Unterhaching, DE
Nairobi, KE
see more
Locations
Mumbai, IN HQ
Macquarie Park, AU
Dhaka, BD
Goiânia, BR
Goiânia, BR
São Paulo, BR
Brampton, CA
see more
Locations
Allschwil, CH HQ
Shanghai, CN
Lörrach, DE
Chiyoda City, JP
Employees
Employees
16,5612% increase
Employees
12,7441% increase
Employees
27,764
Employees
43,000
Employees
8007% increase

Financial

Revenue (est.)
Revenue (est.)
₹167.8b (FY, 2026)
Revenue (est.)
N/A
Revenue (est.)
₹277.1b (FY, 2026)
Revenue (est.)
₹582.2b (FY, 2026)
Revenue (est.)
CHF220.6m (FY, 2025)
Cost of goods
Cost of goods
₹56.9b (FY, 2026)
Cost of goods
N/A
Cost of goods
₹95.5b (FY, 2026)
Cost of goods
₹115.4b (FY, 2026)
Cost of goods
CHF20.9m (FY, 2025)
Gross profit
Gross profit
₹115.8b (FY, 2026)
Gross profit
N/A
Gross profit
₹195b (FY, 2026)
Gross profit
₹488.9b (FY, 2026)
Gross profit
CHF214.3m (FY, 2025)
Net income
Net income
₹3.7b (FY, 2026)
Net income
N/A
Net income
₹38.7b (FY, 2026)
Net income
₹115.6b (FY, 2026)
Net income
(CHF111.7m) (FY, 2025)

Operating

Manufacturing Sites
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
46 (FY, 2024)
Manufacturing Sites
40 (FY, 2025)
Manufacturing Sites
N/A
For sources of this data, please see the company profile

View Company Profiles

EMS Pharma
HQ
BR
Employees
12,744↑ 1% increase

EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.

View company
Cipla
HQ
Mumbai, IN
Employees
27,764

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.

View company
Sun Pharma
HQ
Mumbai, IN
Employees
43,000

Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.

View company
Idorsia
HQ
Allschwil, CH
Employees
800↑ 7% increase

Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.

View company